Search results
Weight loss drug wins 25,000 new US users a week
BBC via Yahoo Finance· 3 days agoThe surge reflects scorching demand for the medicine which, alongside sister diabetes drug Ozempic, has been hailed as revolutionary and helped to...
Scotiabank Raises Loblaw Companies (TSE:L) Price Target to C$161.00
ETF DAILY NEWS· 6 hours agoLoblaw Companies (TSE:L – Free Report) had its target price upped by Scotiabank from C$148.27 to C$161.00 in a report issued on Thursday, BayStreet.CA reports. Scotiabank currently has a sector ...
CIBC Boosts Loblaw Companies (TSE:L) Price Target to C$171.00
ETF DAILY NEWS· 6 hours agoLoblaw Companies (TSE:L – Free Report) had its target price boosted by CIBC from C$159.00 to C$171.00 in a research note issued to investors on Thursday, BayStreet.CA reports. CIBC currently ...
'Blood money': How will Fall River spend its $8M share of opioid settlement funds?
The Herald News via Yahoo News· 2 hours agoFALL RIVER — With the city receiving a windfall of $8 million from settling lawsuits with...
Mark Cuban Cost Plus Drug Company to Supply ScionHealth Utilizing Safecor Health Program
WKBN 27 Youngstown· 4 days agoScionHealth announced today they will begin purchasing certain bulk drugs from Mark Cuban's Cost Plus Drug Company ("Cost Plus Drugs") and delivered to ...
Wells Fargo & Company Lowers Zymeworks (NYSE:ZYME) Price Target to $12.00
ETF DAILY NEWS· 5 hours agoZymeworks (NYSE:ZYME – Get Free Report) had its price objective decreased by analysts at Wells Fargo & Company from $14.00 to $12.00 in a report released on Friday, Benzinga ...
Chinese companies lead ADC pipeline
Pharmaceutical Technology via Yahoo Finance· 4 days agoAlternatively, ProfoundBio is in eighth place by active pipeline ADC count with 13 drugs. This company has developed two distinct proprietary linker-drug
Health Care Climbs as Amgen Surges on Obesity-Drug Plans - Health Care Roundup
Market Watch· 2 days agoHealth-care companies rose after a surprising new entrant in the obesity-drug bonanza from one biotech giant. Amgen shares surged after the biotech giant said it saw encouraging ...
Amgen shares soar as executives outline obesity drug push
BioPharma Dive via Yahoo Finance· 2 days agoThe company said data for its Wegovy competitor was promising enough to move the drug into...
How the CFOs of Eli Lilly and Novo Nordisk are coping with ‘unprecedented demand’ for weight-loss...
Fortune via Yahoo Finance· 2 days agoNovo Nordisk then plans to buy three of Catalent’s manufacturing sites for $11 billion, the company...